Literature DB >> 15205970

The deficit syndrome of the psychotic illness. A clinical and nosological study.

Victor Peralta1, Manuel J Cuesta.   

Abstract

The deficit syndrome is thought to be specific to and a subtype of schizophrenia; however, there are scarce or no data on the prevalence and characteristics of this syndrome in non-schizophrenic psychoses. The aim of this study was to explore the prevalence and correlates of different types of negative symptoms (NegS) in a mixed sample of psychotic disorders. Six-hundred and sixty psychotic inpatients were classified according to the presence and type of NegS into the following groups: no NegS, transitory NegS, persistent secondary NeS, persistent doubtful secondary NegS, and persistent primary NegS (i. e., deficit symptoms). Furthermore, the nosological status of this symptom classification such as its clinical and etiological correlates were examined. Depending on the diagnostic criteria used for diagnosing schizophrenia, the prevalence of the deficit syndrome in schizophrenia and in non-schizophrenic psychoses ranged from 14%-32% and 2%-22%, respectively. Deficit syndromes in both schizophrenic and non-schizophrenic patients shared most of the syndrome-related clinical features. Regarding the associated clinical pattern, the transitory NegS group was closer to the group without NegS than to the groups with enduring NegS. Patient groups with enduring primary and enduring secondary NegS did not show relevant clinical or etiological differences, thus, suggesting that the primary versus secondary issue may be less relevant than previously acknowledged. The deficit syndrome may be diagnosed irrespective of the specific categories of psychotic disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15205970     DOI: 10.1007/s00406-004-0464-7

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  7 in total

Review 1.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

Review 2.  Persistent negative symptoms in schizophrenia: an overview.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-11-10       Impact factor: 9.306

3.  Two subgroups of schizophrenia identified by systematic cognitive neuropsychiatric mapping.

Authors:  István Szendi; Mihály Racsmány; Csongor Cimmer; Gábor Csifcsák; Zoltán Ambrus Kovács; György Szekeres; Gabriella Galsi; Ferenc Tóth; Attila Nagy; Edit Anna Garab; Krisztina Boda; Gergely Gulyás; József Géza Kiss; József Dombi; Csaba Pléh; Zoltán Janka
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-15       Impact factor: 5.270

4.  The factorial structure of the schedule for the deficit syndrome in schizophrenia.

Authors:  David Kimhy; Scott Yale; Raymond R Goetz; Lynn Marcinko McFarr; Dolores Malaspina
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

5.  Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs.

Authors:  Victor Peralta; Lucía Moreno-Izco; Ana Sanchez-Torres; Elena García de Jalón; Maria S Campos; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2012-12-18       Impact factor: 9.306

6.  A New Division of Schizophrenia Revealed Expanded Bilateral Brain Structural Abnormalities of the Association Cortices.

Authors:  István Szendi; Nikoletta Szabó; Nóra Domján; Zsigmond Tamás Kincses; András Palkó; László Vécsei; Mihály Racsmány
Journal:  Front Psychiatry       Date:  2017-07-20       Impact factor: 4.157

7.  Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study.

Authors:  Magnus Johan Engen; Anja Vaskinn; Ingrid Melle; Ann Færden; Siv Hege Lyngstad; Camilla Bärthel Flaaten; Line Hustad Widing; Kristin Fjelnseth Wold; Gina Åsbø; Beathe Haatveit; Carmen Simonsen; Torill Ueland
Journal:  Front Psychiatry       Date:  2022-03-25       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.